Steven I. Sherman - Concepedia

Author

Steven I. Sherman

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

National Thyroid Cancer Treatment Cooperative Study Registr Group, S I Sherman, S Sherman, S. I. Sherman, S. Sherman, S.I. Sherman, STEVEN I. SHERMAN, Sherman, S., Steve I. Sherman, Steven I Sherman

413

Publications

56.4K

Citations

H-Index

104

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Institut Gustave Roussy Johns Hopkins University Massachusetts General Hospital University of Pennsylvania

About

Steven I. Sherman is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	52	7.4K
2	Health Sciences	24	29	5.3K
3	Engineering	6	6	728
4	Natural Sciences	5	5	671
5	Public Health	1	1	66

Steven I. Sherman

176

Publications

34.9K

Citations

H-Index

Page 1

	Year	Citations
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer David S. Cooper, Gerard M. Doherty, Bryan R. Haugen, Thyroid	2009	6.7K
Integrated Genomic Characterization of Papillary Thyroid Carcinoma Nishant Agrawal, Rehan Akbani, Bülent Arman Aksoy, Cell	2014	3K
Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce David S. Cooper, Gerard M. Doherty, Bryan R. Haugen, Thyroid	2006	2K
Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer Martin Schlumberger, Makoto Tahara, Lori J. Wirth, New England Journal of Medicine	2015	2K
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial Marcia S. Brose, Christopher M. Nutting, Barbara Jarząb, The Lancet MedicineIodine Deficiency DisordersRadioactive Iodine-refractoryThyroid DiseaseThyroid Cancer	2014	1.6K
Cabozantinib in Progressive Medullary Thyroid Cancer Rossella Elisei, Martin Schlumberger, Stefan Müller, Journal of Clinical Oncology	2013	1.2K
Outcomes of Patients with Differentiated Thyroid Carcinoma Following Initial Therapy Jacqueline Jonklaas, Nicholas J. Sarlis, Danielle R. Litofsky, Thyroid Surgical OncologyHealth SciencesMedicineRadionuclide TherapyIodine Deficiency Disorders	2006	689
A Comparison of Recombinant Human Thyrotropin and Thyroid Hormone Withdrawal for the Detection of Thyroid Remnant or Cancer1 Bryan R. Haugen, Furio Pacini, Christoph Reiners, The Journal of Clinical Endocrinology & Metabolism Recombinant Human ThyrotropinRadioiodine WbsRecombinant Human TshMedicineThyroid Remnant	1999	564
Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer Razelle Kurzrock, Steven I. Sherman, Douglas W. Ball, Journal of Clinical Oncology	2011	546
Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer Maria A. Kouvaraki, Suzanne E. Shapiro, Bruno D. Fornage, Surgery Medical UltrasoundHealth SciencesMedical ImagingThyroid DiseaseSurgical Management	2003	534

Page 1